22 May 2013
Keywords: USA, FDA Law Blog, Draft REMS, Opioid drugs, Hyman Phelps & McNamara, Prescriber education
Article | 14 July 2010
The US Food and Drug Administration recently released a draft of it class-wide opioid Risk Evaluation and Mitigation Strategy (REMS) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.